VEA
NERV icon

Virtus ETF Advisers’s Minerva Neurosciences NERV Stock Holding History

Virtus ETF Advisers’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,273
Closed -$260K – 260
2017
Q3 		$260K Buy
4,273
+391
+10% +$22.4K 0.04% 137
2017
Q2 		$275K Buy
3,882
+1,281
+49% +$82.9K 0.04% 137
2017
Q1 		$169K Buy
2,601
+249
+11% +$19.3K 0.03% 164
2016
Q4 		$221K Sell
2,352
-852
-27% -$87K 0.07% 168
2016
Q3 		$362K Hold
3,204
– – 0.18% 86
2016
Q2 		$262K Buy
+3,204
New +$204K 0.19% 80

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Virtus ETF Advisers's NERV Position: Q4 2017 in Review

Virtus ETF Advisers sold out of Minerva Neurosciences (NERV) in Q4 2017, closing a stake of 4,273 shares — an estimated $260K sold.

Virtus ETF Advisers first reported a position in NERV in Q2 2016 and held it in 6 quarters. The position peaked at $362K in Q3 2016. 67 funds tracked by Wall St. Rank hold NERV as of Q4 2017.

  • Virtus ETF Advisers reported no remaining Minerva Neurosciences position as of Q4 2017 after selling out during the quarter.
  • Virtus ETF Advisers sold 4,273 Minerva Neurosciences shares in Q4 2017, an estimated $260K.
  • Virtus ETF Advisers first reported a position in Minerva Neurosciences in Q2 2016 and held it in 6 quarters.
  • Virtus ETF Advisers's Minerva Neurosciences position peaked at $362K in Q3 2016.
  • 67 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2017.

Based on Virtus ETF Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.